Minoxidil vs finasteride is one of the most practical questions in androgenetic alopecia (pattern hair loss): which should you start first, and when does combination therapy make sense? In simple terms, minoxidil is a growth-phase support treatment used topically (and sometimes orally under clinician guidance), while finasteride is a prescription DHT blocker mainly used in men with confirmed AGA.
Medical note: This article is for general education and does not provide personal medical advice. If you’re not sure you have pattern hair loss, start here: How Hair Loss Is Diagnosed. If you have scalp pain/burning, pustules/crusting, heavy scale, open sores, or rapid worsening, start here: When to See a Doctor.
Quick navigation
- Key takeaways (fast)
- What each treatment does
- Who each option fits best
- Timeline: when to judge results
- Side effects & red flags
- Can you combine them?
- A practical start plan
- FAQ
- References
Key takeaways (fast)
- Minoxidil is widely used (OTC topical) and supports hair growth when applied consistently; it won’t “cure genetics.”
- Finasteride (1 mg) is a prescription DHT blocker indicated for male pattern hair loss in men; labeling notes you may need 3+ months before benefit is observed.
- Timelines differ: topical minoxidil labeling notes results may appear as early as 2 months, but some men need 4 months; if no results by then, stop use (product labeling).
- Shedding can happen early with minoxidil (often described around the first weeks); use the Minoxidil Shedding guide if this is your main worry.
- Use hubs: Minoxidil Hub • Finasteride & Dutasteride Hub • Androgenetic Alopecia Hub.
What each treatment does
Minoxidil (topical; sometimes oral under clinician guidance)
Minoxidil is used to stimulate hair regrowth and support the growth phase. It is commonly used for AGA and is usually applied to the scalp consistently (often once or twice daily, depending on formulation and clinician advice).
Site roadmap: Minoxidil Hub • Topical Minoxidil • Low-Dose Oral Minoxidil.
Finasteride (oral DHT blocker; men only per FDA labeling)
Finasteride reduces conversion of testosterone to DHT, lowering a key signal that contributes to follicle miniaturization in genetically sensitive scalp areas in AGA.
Site roadmap: Finasteride & Dutasteride Hub • Finasteride: Benefits & Risks.
Who each option fits best
- Minoxidil-first tends to fit: early AGA, people who want an OTC start, and people who prefer to avoid systemic prescriptions initially (assuming no red flags).
- Finasteride tends to fit: men with confirmed AGA who accept prescription therapy and the need to monitor side effects and PSA implications.
- If diagnosis is unclear: avoid random stacking. Use: How Hair Loss Is Diagnosed and the decision guide TE vs Androgenetic Alopecia.
Timeline: when to judge results
- Finasteride: labeling notes that daily use for 3 months or more may be needed before benefit is observed; many people judge response more fairly over months.
- Topical minoxidil: labeling notes results may be seen as early as 2 months, but some need at least 4 months; if no results by 4 months, stop use (label-specific).
- Minoxidil early shedding: can occur early; if you panic-stop too quickly, you may never reach the evaluation window. Use: Minoxidil Shedding.
Side effects & red flags
Minoxidil (topical)
- Scalp irritation/dryness/itch can occur; stop and reassess if severe irritation develops.
- Labeling includes stop-use warnings for systemic symptoms (e.g., chest pain, rapid heartbeat, faintness/dizziness, sudden weight gain, swelling of hands/feet) and advises seeking medical advice.
Finasteride
- Labeling lists sexual adverse reactions in a minority of users.
- Regulators have issued safety communications about psychiatric side effects (including suicidal thoughts) and recommended risk-minimisation measures.
- PSA: 5-alpha reductase inhibitors can lower PSA; always disclose use before PSA testing.
- Pregnancy handling warning: women who are pregnant or may become pregnant should not handle crushed/broken tablets.
Can you combine them?
Yes—many clinician plans use a combination approach (DHT-signal reduction + growth support). The best combination depends on confirmed diagnosis and risk tolerance. A practical way to avoid confusion is to start one change at a time (so you know what caused side effects or shedding changes) and track monthly photos.
A practical start plan
- Confirm pattern: use Androgenetic Alopecia Hub and How Hair Loss Is Diagnosed.
- Choose your “first move”: topical minoxidil if you want an OTC start; finasteride (men) if you want a DHT-blocker approach under clinician guidance.
- Set a fair evaluation window: measure in months, not weeks.
- Track with structure: photos every 4 weeks (same lighting/angle) + note side effects.
FAQ
Which is better: minoxidil or finasteride?
They target different parts of the problem. Many people use one or both depending on diagnosis, goals, and side-effect tolerance.
Can I start both at the same time?
Some do, but if you want clean troubleshooting, changing one variable at a time makes side effects and shedding changes easier to interpret.
If I shed early on minoxidil, should I stop?
Not automatically. Early shedding can occur; use the dedicated guide and reassess if shedding persists outside the expected early window or if red flags appear.
References (trusted medical sources)
- AAD: Male pattern hair loss treatment (minoxidil + finasteride options)
- FDA label (Propecia / finasteride 1 mg): men-only indication, timeline, warnings
- FDA label (5% topical minoxidil example): timeline, stop-use warnings
- BAD leaflet: male pattern hair loss (minoxidil early shed 4–6 weeks; trial length)
- DermNet NZ: Minoxidil solution (time to response)
- EMA: finasteride/dutasteride risk-minimisation (psychiatric warning context)
Last updated: February 28, 2026.
